These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 793712)

  • 1. Evaluation of the mutagenicity of compounds of known carcinogenicity, belonging to the benz[a]anthracene, chrysene, and cyclopenta[a]phenanthrene series, using Ames's test.
    Coombs MM; Dixon C; Kissonerghis AM
    Cancer Res; 1976 Dec; 36(12):4525-9. PubMed ID: 793712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity and tumorigenicity of phenanthrene and chrysene epoxides and diol epoxides.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Mah HD; Karle JM; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1979 Oct; 39(10):4069-77. PubMed ID: 383279
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds.
    Wood AW; Levin W; Chang RL; Huang MT; Ryan DE; Thomas PE; Lehr RE; Kumar S; Koreeda M; Akagi H; Ittah Y; Dansette P; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Mar; 40(3):642-9. PubMed ID: 7471084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogenicity and mutagenicity of benz(a)anthracene diols and diol-epoxides.
    Slaga TJ; Huberman E; Selkirk JK; Harvey RG; Bracken WM
    Cancer Res; 1978 Jun; 38(6):1699-704. PubMed ID: 647680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylene-bridged bay region chrysene and phenanthrene derivatives and their keto-analogs: mutagenicity in Salmonella typhimurium and tumor-initiating activity on mouse skin.
    Rice JE; Makowski GS; Hosted TJ; Lavoie EJ
    Cancer Lett; 1985 Jun; 27(2):199-206. PubMed ID: 3891075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenicity and mutagenicity of the 3,4-dihydrodiols and other metabolites of 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives.
    Wislocki PG; Gadek KM; Chou MW; Yang SK; Lu AY
    Cancer Res; 1980 Oct; 40(10):3661-4. PubMed ID: 6777036
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of specific monooxygenases by isosteric heterocyclic compounds of benz[a]anthracene, benzo[c]phenanthrene and chrysene.
    Jacob J; Schmoldt A; Raab G; Hamann M; Grimmer G
    Cancer Lett; 1983 Oct; 20(3):341-8. PubMed ID: 6688754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epoxides of carcinogenic polycyclic hydrocarbons are frameshift mutagens.
    Ames BN; Sims P; Grover PL
    Science; 1972 Apr; 176(4030):47-9. PubMed ID: 4551487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic activity of chemical carcinogens and related compounds in the intraperitoneal host-mediated assay.
    Simmon VF; Rosenkranz HS; Zeiger E; Poirier LA
    J Natl Cancer Inst; 1979 Apr; 62(4):911-8. PubMed ID: 372659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the skin tumor-initiating activities of dihydrodiols and diol-epoxides of various polycyclic aromatic hydrocarbons.
    Slaga TJ; Gleason GL; Mills G; Ewald L; Fu PP; Lee HM; Harvey RG
    Cancer Res; 1980 Jun; 40(6):1981-4. PubMed ID: 7371034
    [No Abstract]   [Full Text] [Related]  

  • 13. The association of bacterial mutagenicity of hydrocarbon-derived 'bay-region' dihydrodiols with the Iball indices for carcinogenicity and with the extents of DNA-binding on mouse skin of the parent hydrocarbons.
    Bartsch H; Malaveille C; Tierney B; Grover PL; Sims P
    Chem Biol Interact; 1979 Jul; 26(2):185-96. PubMed ID: 110477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of some dihydrodiols of several polycyclic aromatic hydrocarbons to mutagenic products by prostaglandin synthetase.
    Guthrie J; Robertson IG; Zeiger E; Boyd JA; Eling TE
    Cancer Res; 1982 May; 42(5):1620-3. PubMed ID: 6279279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity and tumor-initiating activity of fluorinated derivatives of 7,12-dimethylbenz(a)anthracene.
    Huberman E; Slaga TJ
    Cancer Res; 1979 Feb; 39(2 Pt 1):411-4. PubMed ID: 104789
    [No Abstract]   [Full Text] [Related]  

  • 18. The mutagenicity of chemically synthesized metabolites of 16,17-dihydro-15H-cyclopenta[a]phenanthrene and its carcinogenic 11-methyl homologue.
    Papaparaskeva-Petrides C; Ioannides C; Boyd GW; Young RJ; Harvey RG; Coombs MM
    Mutagenesis; 1993 Jul; 8(4):307-10. PubMed ID: 8377648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for bay region activation of chrysene 1,2-dihydrodiol to an ultimate carcinogen.
    Levin W; Wood AW; Chang RL; Yagi H; Mah HD; Jerina DM; Conney AH
    Cancer Res; 1978 Jun; 38(6):1831-4. PubMed ID: 647691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells.
    Glatt H; Piée A; Pauly K; Steinbrecher T; Schrode R; Oesch F; Seidel A
    Cancer Res; 1991 Mar; 51(6):1659-67. PubMed ID: 1900215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.